By proceeding, you agree to our Terms of Use and Privacy Policy.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.
25-27 April 2022
Built with Genentech, AstraZeneca, Starpharma, Avidity, and Guardian Therapeutics, join 80+ key leaders and decision makers as they reimagine traditional ADCs and discuss their novel format technologies.
Event Ended
USA
Paid
Boston
06-09 September 2022
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
San Diego
15-16 September 2022
Welcome to the Vaccine Technology Summit 2022, where global biotech and pharmaceutical companies will meet with leading vaccine experts in London, UK, to explore new vaccine technologies to discover, develop, and manufacture next-generation vaccines.
UK
London
02-04 November 2022
Biologic drug discovery, development, manufacturing, pricing & market access, Clinical Trials. The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
Switzerland
Basel
14-16 November 2022
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe.
Spain
Barcelona
06-08 December 2022
With the ever-increasing competitive nature of the ADC field, target selection is a key differentiator between having a failed or successful ADC. Being able to optimally triangulate the choice of linker-payload, target and indication is vital in deve
21-23 February 2023
With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads a
13-16 March 2023
The 13th Annual World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before! With the recent approval of Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, s
20-22 March 2023
The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
22-24 August 2023
The ADC Linker & Conjugation Summit is a significant event for those involved in developing ADC drugs. With the increasing use of site-specific ADCs, the development of new conjugation technologies and linker chemistry, as well as the expansion of th
19-21 September 2023
Welcome to the Inaugural ADC Process Development SummitAs more ADCs receive Accelerated Approval and Fast Track Designation, expediting the transition to the clinic becomes a strategic priority for developers. This underscores the growing need of
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea